Ziprasidone Impurity 13 CAS CATO-C4X-124013
| CAS No. | CATO-C4X-124013 |
| Molecular Formula | C10H9Cl2NO |
| Molecular Weight | 230.09 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Ziprasidone Impurity 13.
Ziprasidone Impurity 13 (CAS CATO-C4X-124013) is a certified pharmaceutical impurity reference standard with the molecular formula C10H9Cl2NO and a molecular weight of 230.09 g/mol.
The molecular framework of Ziprasidone Impurity 13 (C10H9Cl2NO) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Ziprasidone Impurity 13 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C10H9Cl2NO |
| Molecular Weight | 230.09 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor, faint amine-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 6.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 1 |
Related Ziprasidone Standards
- Ziprasidone Impurity 38 (CAS CATO-C4X-124038)
- Ziprasidone Impurity 9 (CAS 118289-55-7)
- Ziprasidone Impurity 19 (CAS 147124-37-6)
- Ziprasidone impurity 50 (CAS 128396-56-5)
- Ziprasidone Impurity 77 (CAS 1455471-51-8)
- Ziprasidone EP Impurity A (CAS 87691-87-0)
- Ziprasidone Impurity 26 (CAS 118307-04-3)
- Ziprasidone Impurity 33 (CAS CATO-C4X-124033)
Recommended Standards
- Pentafluoroallyl fluorosulfate (CAS 67641-28-5)
- N-(2,5-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine (CAS 56514-55-7)
- n-(2,2-Dichloroethenyl)-4-methylbenzamide (CAS 54888-30-1)
- Tolvaptan Impurity 74 (CAS CATO-C4X-195574)
- Ticagrelor Impurity 153 (CAS CATO-C4X-1093153)
- Eperisone Impurity 40 (CAS 1806363-55-2)
- Imatinib Impurity 85 (CAS 909342-95-6)
- 5-Ethyl-6-methyl-4-pentyl-3,4-dihydropyrimidin-2(1H)-one (CAS 728004-28-2)
- TERT-BUTYL 4,4-DIETHOXYBUTYLCARBAMATE (CAS 143646-48-4)
- Terbutaline Impurity 32 (CAS CATO-C4X-118332)
- 3-Hexyl-5-((3-(4-isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one (CAS 623934-91-8)
- 9-Vinylphenanthrene (CAS 14134-06-6)
- tert-Butyl 2-chloro-7-methoxy-1H-indole-1-carboxylate (CAS 1881331-18-5)
- Osteogenic Growth Peptide (10-14) (CAS 105250-85-9)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com